Pharmaceutical Companies Make the News Again for FLSA Suits by Drug Reps

Another week means another decision from the Southern District of New York affecting FLSA suits by former pharmaceutical representatives against their employers! Like the recent Amendola decision, the federal judge in Coultrip et al. v. Pfizer, Inc., case number 06-9952, was not persuaded by Pfizer's argument that the drug reps could never establish an entitlement to overtime pay because of the outside sales exemption, but the judge was also unwilling to rule that the defense raised by Pfizer should be struck in the action.

The end result of this new decision is that pharmaceutical companies and their counsel will have more decisions and opinions to review, distinguish and track in the coming months. Take a look at our recent client alert on this topic, by clicking here.